DA Davidson lowered the firm's price target on BlueLinx to $68 from $75 and keeps a Neutral rating on the shares. The company's Q3 results were highlighted by encouraging Specialty volumes growth and flat pricing, though the firm is taking a more conservative stance around the 2026 demand environment and commodity pricing assumptions, the analyst tells investors in a research note.
